RxDoctor Payments Data

Heather Abernathy

Family · Hot Springs, ARNPI 1184255226

Payments from drug & device makers

$3,085in general payments, 2019–2025

Across 148 payments — averaging $20.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Radius Health, Inc.$1K
  • Amgen$994
  • Vertex$226
  • Bioventus LLC$131
  • Pacira Pharmaceuticals Incorporated$127
  • Stryker$63
  • plus $476 from 16 others

What the payments were for

  • Food & beverage$3,085100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,085 in reported general payments places this provider in the 85th percentile of 2,103 family providers in Arkansas.

See all family providers in Arkansas

Medicare billing

Part B allowed, 2024
$398,839
Medicare patients
415
Services billed
28,828

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Evenity (2 Syringes)Romosozumab-Aqqg74$185,742
TymlosAbaloparatide18$47,904
ProliaDenosumab14$25,106
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen171$1,447
Diclofenac Sodium47$569
Doxycycline Hyclate22$470
Cyclobenzaprine Hcl31$296
Meloxicam63$287
Methylprednisolone31$249
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim30$159
Ibuprofen24$143
Acetaminophen-CodeineAcetaminophen With Codeine20$133
Omeprazole13$131
Gabapentin20$121
Tramadol Hcl51$112

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenEvenity (2 Syringes), Prolia$994$210,84988 claims
Radius Health, Inc.Tymlos$1,068$47,90418 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,103 family providers in Arkansas.

Other family in Hot Springs

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →